In this interview, Dr. David Rosenberg discusses practical considerations when it comes to atypical psychopharmacologic strategies in children and adolescents and tackles common concerns, such as dosing considerations, possible adverse effects, and tapering strategies. He also addresses questions regarding the use of atypical psychopharmacologic agents for specific clinical concerns, such as insomnia, obsessive-compulsive disorder, and self-injurious behaviors.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/atypical-psychopharmacologic-strategies-for-children-and-adolescents-interview-2730?utm_source=PDF+CME+Program&utm_medium=PDF+CME+Program&utm_campaign=PDF+CME+Program
- Start Date: 2023-07-01 05:00:00
- End Date: 2023-07-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest